Blue Trust Inc. Buys 2,814 Shares of National Health Investors, Inc. (NYSE:NHI)

Blue Trust Inc. grew its position in shares of National Health Investors, Inc. (NYSE:NHI) by 378.7% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,557 shares of the real estate investment trust’s stock after purchasing an additional 2,814 shares during the quarter. Blue Trust Inc.’s holdings in National Health Investors were worth $299,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Strategic Financial Concepts LLC bought a new position in National Health Investors during the second quarter worth $28,000. International Assets Investment Management LLC acquired a new position in shares of National Health Investors in the 2nd quarter valued at about $36,000. USA Financial Formulas boosted its position in shares of National Health Investors by 172.8% during the 3rd quarter. USA Financial Formulas now owns 922 shares of the real estate investment trust’s stock valued at $78,000 after purchasing an additional 584 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of National Health Investors by 66.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 2,594 shares of the real estate investment trust’s stock valued at $163,000 after purchasing an additional 1,033 shares in the last quarter. Finally, Shayne & Jacobs LLC acquired a new stake in National Health Investors during the second quarter worth approximately $210,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Stock Down 0.8 %

National Health Investors stock opened at $75.85 on Friday. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.91. The firm’s fifty day moving average price is $80.54 and its two-hundred day moving average price is $72.01. The firm has a market capitalization of $3.30 billion, a price-to-earnings ratio of 25.80, a price-to-earnings-growth ratio of 4.73 and a beta of 1.04. National Health Investors, Inc. has a 1-year low of $48.97 and a 1-year high of $86.13.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.10 by ($0.29). The company had revenue of $84.97 million for the quarter, compared to analyst estimates of $64.95 million. National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. National Health Investors’s revenue for the quarter was up 9.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.06 EPS. On average, equities research analysts predict that National Health Investors, Inc. will post 4.52 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Friday, September 27th will be issued a dividend of $0.90 per share. The ex-dividend date is Friday, September 27th. This represents a $3.60 annualized dividend and a yield of 4.75%. National Health Investors’s dividend payout ratio (DPR) is currently 122.45%.

Analysts Set New Price Targets

A number of research firms have issued reports on NHI. Wells Fargo & Company cut National Health Investors from an “overweight” rating to an “equal weight” rating and increased their price target for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. StockNews.com downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Truist Financial increased their price objective on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. Finally, Bank of America started coverage on National Health Investors in a research note on Tuesday, September 24th. They issued a “buy” rating and a $92.00 target price for the company. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $73.29.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.